For the quarter ending 2026-03-31, CPMD has $6,580,734 in assets. $36,850,622 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 633 | 1,804 | 927 | 16,975 |
| Accounts receivable | - | - | 588,393 | 114,307 |
| Goods and services tax receivable | 19,064 | 29,832 | 17,628 | 23,204 |
| Accounts receivable | 6,944 | 164,430 | - | - |
| Inventory | 902,913 | 1,115,322 | 863,807 | 1,043,538 |
| Total current assets | 929,554 | 1,311,388 | 1,470,755 | 1,198,024 |
| Equipment, net | 176,101 | 127,029 | 123,333 | 129,389 |
| Right-of-use building, net | 5,475,079 | 5,579,987 | 5,504,692 | 5,627,215 |
| Investments | - | 0 | 4,518,127 | 4,518,127 |
| Total assets | 6,580,734 | 7,018,404 | 11,616,907 | 11,472,755 |
| Accounts payable and accrued liabilities | 10,232,578 | 10,059,415 | 10,189,279 | 10,012,932 |
| Accrued interest | 2,157,329 | 1,720,278 | 1,522,539 | 3,865,183 |
| Deferred revenue | 0 | 260,561 | - | - |
| Notes payable | 478,270 | 482,661 | 478,604 | 483,874 |
| Convertible notes | 1,017,004 | 1,017,004 | 1,017,003 | 1,298,114 |
| Derivative conversion feature | 1,208,438 | 2,009,476 | 556,755 | 564,051 |
| Loans payable to related parties, current portion | 13,130,027 | 12,567,911 | 11,885,572 | - |
| Royalty payable | 429,520 | 305,492 | 287,035 | 56,405 |
| Loans payable to related parties | - | - | - | 9,941,556 |
| Liability for right-of-use building, current portion | 983,755 | 1,000,479 | 985,027 | 1,005,099 |
| Obligation to issue shares | 1,849,155 | 2,166,681 | 1,558,710 | 1,727,065 |
| Total current liabilities | 31,486,076 | 31,589,958 | 28,480,524 | 28,954,279 |
| Loans payable to related parties | 433,696 | 548,574 | 679,397 | - |
| Liability for right-of-use building | 4,930,850 | 5,033,601 | 4,973,729 | 5,092,561 |
| Preferred stock, value-Series BPreferred Stock | - | - | - | 455,000 |
| Total liabilities | 36,850,622 | 37,172,133 | 34,133,650 | 34,046,840 |
| Preferred stock value-Series APreferred Stock | 74,416 | 74,416 | 74,416 | 74,416 |
| Preferred stock, value-Series DPreferred Stock | - | - | 455,000 | - |
| Preferred stock value-Series BPreferred Stocks | 455,000 | 455,000 | - | - |
| Preferred stock value-Series CPreferred Stock | 100,000 | 100,000 | 100,000 | 100,000 |
| Common shares, 0.0001 par value 5,000,000,000 and 5,000,000,000 shares authorized, 678,501,405 and 662,501,405 issued and outstanding as at march 31, 2026 and december 31, 2025, respectively | 67,850 | 66,250 | 66,250 | 66,250 |
| Shares to be issued | 0 | 1,600 | - | - |
| Treasury shares, 0.0001 par value 6,230,761 shares as at september 30, 2025 and december 31, 2024 | - | - | 623 | 623 |
| Treasury shares, 0.0001 par value 6,230,761 shares as at march 31, 2026 and december 31, 2025 | 623 | 623 | - | - |
| Additional paid-in capital | 81,520,643 | 81,520,643 | 81,379,443 | 80,122,590 |
| Accumulated deficit | -112,697,611 | -112,315,590 | -104,766,005 | -103,288,194 |
| Accumulated other comprehensive income | 209,191 | -56,671 | 173,530 | -104,770 |
| Total shareholders' deficit | -30,269,888 | -30,153,729 | -22,516,743 | -22,574,085 |
| Total liabilities and shareholders' deficit | 6,580,734 | 7,018,404 | 11,616,907 | 11,472,755 |